Founded in 1991, Albany Molecular Research, Inc. (NASDAQ: AMRI) is a leading chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies and is developing new chemistry technology for potential pharmaceutical products. AMRI has expertise in comprehensive chemistry applications required in small molecule drug discovery and development, from the earliest stages of lead generation and optimization through chemical process development and cGMP synthesis.